Neuroendocrine tumors (NETs) are heterogeneous malignancies arising from the diffuse
neuroendocrine system. They frequently originate in the gastroenteropancreatic (GEP) tract …

ABSTRACT Background Pulmonary carcinoids (PCs) are rare tumors. As there is a paucity
of randomized studies, this expert consensus document represents an initiative by the …

PURPOSE Patients with advanced pancreatic neuroendocrine tumors (NETs) have few
treatment options that yield objective responses. Retrospective and small prospective …

M. Pavel a D. O'Toole b F. Costa c J. Capdevila d D. Gross e R. Kianmanesh f E. Krenning g
U. Knigge h R. Salazar i U.-F. Pape a K. Öberg j all other Vienna Consensus Conference …

Neuroendocrine tumors (NETs) comprise a broad family of tumors that may or may not be
associated with symptoms attributable to hormonal hypersecretion. The NCCN Clinical …

Purpose We evaluated the efficacy and safety of capecitabine and temozolomide (CAPTEM)
in patients with metastatic neuroendocrine tumors (NETs) to the liver. This regimen was …

The capecitabine and temozolomide (CAPTEM) regimen is active in the treatment of
metastatic pancreatic neuroendocrine tumors (pNETs), with response rates ranging from 30 …

Purpose The clinical benefit of peptide receptor radionuclide therapy (PRRT) in patients with
pancreatic neuroendocrine tumours (pNET) has not yet been well described and defined in …

Purpose Treatment options for neuroendocrine tumors (NETs) remain limited. This trial
assessed the progression-free survival (PFS) of bevacizumab or interferon alfa-2b (IFN-α …

Antibody based positron emission tomography (immuno‐PET) imaging is of increasing
importance to visualize and characterize tumor lesions. Additionally, it can be used to …